Latest filing published 17 Sept 2021 for Vanda Pharmaceuticals Inc., €44k.
Filing timeline
BuySaleInsider track record
Aranthan Jones II: trading record in brief
Aranthan Jones II, listed as senior executive, appears in our data through filings on Vanda Pharmaceuticals Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 27 July 2020 and the latest from 15 September 2021.
No open-market purchase appears, only 3 sales worth €259k. The rest of the record consists of 1 option exercise. 2021 to date brings no purchases and 1 sale.
The record was last updated on 17 September 2021 with an option exercise (€44k) in Vanda Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Aranthan Jones II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,277 shares@ US$12.2726.9% of flowCommon StockSEC:0001209191-21-056530:0
- 7,250 shares@ US$19.693373.1% of flowCommon StockSEC:0001209191-21-048276:0
- 7,200 shares@ US$11.81Common StockSEC:0001209191-20-046804:0
- 7,313 shares@ US$10.62Common StockSEC:0001209191-20-043998:0
4 of 4 declarations
